Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer

Pancreatic adenocarcinoma (PDAC) still represents a devastating disease associated with a very limited survival. Novel biomarkers allowing an early diagnosis as well as an optimal selection of suitable treatment options for individual patients are urgently needed to improve the dismal outcome of PDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Loosen, Sven H., Luedde, Mark, Lurje, Georg, Spehlmann, Martina, Paffenholz, Pia, Ulmer, Tom Florian, Tacke, Frank, Vucur, Mihael, Trautwein, Christian, Neumann, Ulf P., Luedde, Tom, Roderburg, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854939/
https://www.ncbi.nlm.nih.gov/pubmed/31772690
http://dx.doi.org/10.1155/2019/5603474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854939/
https://www.ncbi.nlm.nih.gov/pubmed/31772690
http://dx.doi.org/10.1155/2019/5603474

Ejemplares similares